skin rash after targeted medicine and immunotherapy for malignant tumors
Conditions
Interventions
Treatment group:zicao decoction
Control group:Hydrocortisone Butyrate Cream
Sponsors
Shanghai Municipal Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: ? Age greater than 18 years old; ? Patients with malignant tumors diagnosed by cytology or pathology who have undergone targeted therapy or immunotherapy; ? Meet the diagnostic criteria of rash after targeted and immunotherapy for malignant tumors; ? Disease grading meets mild or moderate, without acute skin infection and cellulitis; ? Karnofsky score = 60; ? Expected survival is more than 3 months.
Exclusion criteria
Exclusion criteria: ? Severe allergy; ? The presence of severe maculopapular rash, eczema, papular oozing, erythema, exfoliative dermatitis and other skin lesions on the localized skin of the affected limbs; ? Acute skin infections and cellulitis on the localized skin of the affected limbs; ? Combined with serious primary diseases such as cardiac, cerebrovascular, hepatic, renal and hematopoietic systems.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| affected area;efficacy index; | — |
Secondary
| Measure | Time frame |
|---|---|
| basic information;safety assessment; | — |
Countries
China
Contacts
Public ContactWeikang Zhu
Shanghai Municipal Hospital of Traditional Chinese Medicine
Outcome results
None listed